Evidence map›Paper›PMID 36634627›Full record

ArticleOphthalmic research2023

Elaborate Evaluation of Farnsworth Dichotomous D-15 Panel Test Can Help Differentiate between Best Vitelliform Macular Dystrophy and Autosomal Recessive Bestrophinopathy.

Katarzyna Nowomiejska, Fadi Nasser, Agnieszka Brzozowska, Robert Rejdak, Eberhart Zrenner

Abstract read
In one paragraph

Article in Ophthalmic research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Practice Effects and the Lanthony D15.Vision (Basel, Switzerland) · 2026
    Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katarzyna NowomiejskaChair and Department of General and Pediatric Ophthalmology, Medical University of Lublin, Lublin, Poland.
Fadi NasserCenter for Ophthalmology, Institute for Ophthalmic Research, Eberhard Karls University, Tuebingen, Germany.
Agnieszka BrzozowskaDepartment of Informatics and Medical Biostatistics, Medical University of Lublin, Lublin, Poland.
Robert RejdakChair and Department of General and Pediatric Ophthalmology, Medical University of Lublin, Lublin, Poland.
Eberhart ZrennerCenter for Ophthalmology, Institute for Ophthalmic Research, Eberhard Karls University, Tuebingen, Germany.

Funding

Therapeutic gene editing and multimodal imaging in juvenile macular degeneration R24EY028758 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AUDO , ISABELLE, SPARROW, JANET RUTHE · 2020 to 2024
$10.9M
NEI NIH HHS R24 EY028758
6 · The paper itself

Abstract

introductionThe colour vision in bestrophinopathies has not been assessed in detail so far. The aim of this study was to explore the extent to which distinct types of bestrophinopathies differ in regard to colour vision deficiencies using Farnsworth Dichotomous D-15 and Lanthony Desaturated D-15 panel tests.

methodsBoth D-15 tests were performed in 52 eyes of 26 patients with Best vitelliform macular dystrophy (BVMD) and 10 eyes of 5 patients with autosomal recessive bestrophinopathy (ARB). Two methods were used for a quantitative assessment of the colour vision deficiencies: moment of inertia method and Bowman method. The following parameters were calculated: confusion angle, confusion index (C-index), selectivity index (S-index), total error score (TES), and colour confusion index (CCI).

resultsThe median value of confusion angle for all stages of BVMD fell into a narrow range around 62, indicating normal results. The median confusion angle value was 57 in ARB patients within a very wide range down to -82, indicating non-specific deficits. These differences were statistically significant. Significantly abnormal C-index and CCI values were found only in ARB patients, being 2.0 and 1.49, respectively. The majority of parameters of D-15 tests were independent of the visual acuity in both bestrophinopathies.

conclusionsElaborate evaluation of the D-15 panel tests might help establish a differential diagnosis between different bestrophinopathies, as the pattern of the colour vision loss is different between BVMD and ARB. The quantitative parameters of colour vision tests in bestrophinopathies are independent of the visual acuity.

Indexed as

Color Vision DefectsVitelliform Macular DystrophyAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsBestrophinsEye Diseases, HereditaryHumansRetinal DiseasesTomography, Optical CoherenceAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsBestrophinsAutosomal recessive bestrophinopathyBestrophinopathiesBest vitelliform macular dystrophyColour visionD-15 panel

Identifiers

PMID36634627
PMCPMC11149457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.